News: cancer research
Fighting cancer from within
Lung cancer is the leading cause of cancer-related deaths in Australia, taking the lives of an estimated 8,900 people last year alone.
Glenda's story
When Glenda was diagnosed with stage 4 non-small cell lung cancer in 2014 at just 57 years old, she was in shock. “I had never smoked a day in my life,” Glenda said.
SAiGENCI researcher awarded funding for breast cancer research
Dr Joanna Achinger-Kawecka has been awarded a National Breast Cancer Foundation (NBCF) 2025 Research Project Grant, providing essential support for investigator-initiated research projects which are critical to building Australia's breast cancer research pipeline and addressing critical research questions.
[Read more about SAiGENCI researcher awarded funding for breast cancer research]
SAiGENCI researcher awarded funding in latest MRFF round
A SAiGENCI project using nanotechnology has received funding in the latest round of Medical Research Future Fund (MRFF) Early-to-Mid Career Researchers funding.
[Read more about SAiGENCI researcher awarded funding in latest MRFF round]
Lorne Cancer Conference 2025
The South Australian immunoGENomics Cancer Institute (SAiGENCI) and Adelaide Centre for Epigenetics (ACE) were well represented at the 37th annual Lorne Cancer Conference held from the 13th to 15th of February in Lorne, a coastal town on the Great Ocean Road in Victoria.
New role brings hope for SA cancer patients
Eradicating cancer from being a terminal disease to one we can successfully manage and treat is the holy grail of cancer research – and the grand vision of a new Molecular Cancer Pathology Fellow being co-funded by The Hospital Research Foundation Group.
[Read more about New role brings hope for SA cancer patients]
SAiGENCI researcher granted national health funding
SAiGENCI research into using PROTACs for cancer treatments has been funded in the latest round of the National Health and Medical Research Council (NHMRC) Investigator Grants.
[Read more about SAiGENCI researcher granted national health funding]
SAiGENCI researchers awarded funding through NHMRC program
Two SAiGENCI research groups are among nine from the Faculty of Health and Medical Sciences awarded funding through the latest round of the National Health and Medical Research Council (NHMRC) Ideas Grants.
[Read more about SAiGENCI researchers awarded funding through NHMRC program]
Developing the first drug for multi-organ radiation protection
A pharmaceutical breakthrough at the University of Adelaide is showing promise in both multi-organ radiation protection and cancer treatment.
[Read more about Developing the first drug for multi-organ radiation protection]
Meet our researchers: Dharmesh D Bhuva
Dr Dharmesh D Bhuva, Postdoctoral Research Fellow, South Australian ImmunoGENomics Cancer Institute (SAiGENCI).
